Full Data
Net profit has been declining year after year, and sales expenses have been high. Kexing Pharma has made every effort to promote the listing cost of new crown oral drugs – yqqlm
-
Post Lock
Caishen.CoPrimary Data for China's Secondary Investment and Stock Markets